Sunfed meats are made from plant protein, they cook, feel and taste just like animal meat but are healthier, both for you and the planet.
Biotechnology consultant Topaz Conway, here as part of the Vogue Codes series, writes about how women can make their mark in the entrepreneurial world.
Tales of paths travelled always deliver enduring anticipation, where the expectation is for triumph to reign and the pioneers to reap the benefits of their journey. The battleground of gender diversity has been fought by fearless trailblazers to create equal opportunity, where women are recognised for their contribution and efforts to business and economic development. And it’s the work of Springboard Enterprises Australia, along with its parent affiliate in the US, co-founded in 2000 by prominent American businesswoman and visionary Kay Koplovitz, that has created an opportunity for entrepreneurial women, an avenue to turn their dreams and ideas into reality.
Agriculture has come a long way in the past century. We produce more food than ever before — but our current model is unsustainable, and as the world’s population rapidly approaches the 8 billion mark, modern food production methods will need a radical transformation if they’re going to keep up. But luckily, there’s a range of new technologies that might make it possible. In this series, we’ll explore some of the innovative new solutions that farmers, scientists, and entrepreneurs are working on to make sure that nobody goes hungry in our increasingly crowded world.
Corn isn’t the sexiest crop but it’s one of the most important. It’s the most abundant grain on Earth, used as food and biofuel around the globe. In ancient times, Mesoamericans thrived on it, waged wars over it. Their myths claimed corn was the matter from which gods created mankind itself.
Viome, the wellness monitoring service founded by Seattle-area tech entrepreneur Naveen Jain, has raised $15 million this month in an investment round, according to documents filed today with the Securities and Exchange Commission.
The equity sale boosts the first commercial venture brought to life by Jain’s BlueDot innovation factory.
Jain deferred comment on the details of the investment today, but in an April interview, he said Viome was just the kind of technological moonshot BlueDot was designed to foster.
Family movie night can be fraught in biotech households.
Earlier this month, John Crowley, CEO of Amicus Therapeutics, cued up “Rise of the Planet of the Apes” as a refresher before the debut of its blockbuster sequel. Soon his living room played host to a man with roughly his job, working at a firm not unlike his, but whose greed and moral depravity made him the movie’s villain.
“Here we go, dad,” Crowley recalled the teenage John Jr. saying. “Another evil biotech company ruining the world.”
Fighting climate change is one thing; doing so while people in power actively deny and ignore it makes the challenge nearly impossible. Just this week, Trump nominated non-scientist Sam Clovis, a climate change-denying conservative, as the USDA’s top scientist. He also has no background in agriculture, food or any type of policy making. He has said he will not prioritize climate change at the USDA, calling climate change “junk science” and “not proven.”
This obvious war on science is not new. Oil and gas lobbyists have paid scientists and blocked climate change policies for years, corrupting those who should be standing up for the planet (and the people). This anti-climate stance has trickled down to people as well. Take for instance some of the comments on last week’s green digest; one commenter linked to the financial right-wing conspiracy ZeroHedge’s article of the “climate change hoax,”’ one directed readers to a misinformation site called ClimateDepot and another referred to climate change as pseudoscience.
At first, IndieBio’s offices look like another San Francisco workspace, complete with young people in hoodies slurping coffee and gazing at their laptops. But in the basement, is a laboratory where scientists are advancing some remarkable technology.
IndieBio is the world’s biggest biotech accelerator, providing early stage businesses with $250,000 (£192,000) funding, mentoring and rapid business development. It only backs the most ambitious of enterprises. “Either you need to make a lot of money, or blow people’s minds. Anything that falls in between – forget about it,” says IndieBio’s co-founder, Ryan Bethencourt.
By continuing to delay significant reductions in greenhouse gas emissions, we risk handing young people alive today a bill of up to US$535 trillion. This would be the cost of the “negative emissions” technologies required to remove CO₂ from the air in order to avoid dangerous climate change.
These are the main findings of new research published in Earth System Dynamics, conducted by an international team led by US climate scientist James Hansen, previously the director of NASA’s Goddard Institute for Space Studies.
JNJ is covered by 9 analysts who by consensus are expecting a 30.6% increase in earnings over the next 3 years. This would see the EPS rise to $8.07 levels which would no doubt please investors who are used to an average of $5.75 over the past few years.
This will project the annual earnings to levels above what has been seen in the past few years.
During the same time revenue is predicted to grow from $72.17 Billion to $84.38 Billion in 2020 and profit is predicted to escalate from $16.50 Billion to $22.89 Billion in 2020, roughly growing 1.4x. Margins are expected to be extremely healthy during this time as well.
By blocking of an enzyme that affects the cellular microenvironment it is possible to stop brain tumour cells from growing. This is shown in a new study published in the journal Molecular Cancer Therapeutics by researchers at Uppsala University in collaboration with researchers in Haifa, Israel and Brisbane, Australia.
Brain tumours constitute 25% of all childhood cancers. Among those are malignant forms such as medulloblastoma, a cancer of the cerebellum.